001     137691
005     20240321220309.0
024 7 _ |a 10.1016/j.ajhg.2014.10.013
|2 doi
024 7 _ |a pmid:25466870
|2 pmid
024 7 _ |a pmc:PMC4259973
|2 pmc
024 7 _ |a 0002-9297
|2 ISSN
024 7 _ |a 1537-6605
|2 ISSN
024 7 _ |a altmetric:2909138
|2 altmetric
037 _ _ |a DZNE-2020-04013
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 0
|e First author
245 _ _ |a Absence of BiP co-chaperone DNAJC3 causes diabetes mellitus and multisystemic neurodegeneration.
260 _ _ |a New York, NY
|c 2014
|b Elsevier
264 _ 1 |3 print
|2 Crossref
|b Elsevier BV
|c 2014-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1710759727_18975
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Diabetes mellitus and neurodegeneration are common diseases for which shared genetic factors are still only partly known. Here, we show that loss of the BiP (immunoglobulin heavy-chain binding protein) co-chaperone DNAJC3 leads to diabetes mellitus and widespread neurodegeneration. We investigated three siblings with juvenile-onset diabetes and central and peripheral neurodegeneration, including ataxia, upper-motor-neuron damage, peripheral neuropathy, hearing loss, and cerebral atrophy. Exome sequencing identified a homozygous stop mutation in DNAJC3. Screening of a diabetes database with 226,194 individuals yielded eight phenotypically similar individuals and one family carrying a homozygous DNAJC3 deletion. DNAJC3 was absent in fibroblasts from all affected subjects in both families. To delineate the phenotypic and mutational spectrum and the genetic variability of DNAJC3, we analyzed 8,603 exomes, including 506 from families affected by diabetes, ataxia, upper-motor-neuron damage, peripheral neuropathy, or hearing loss. This analysis revealed only one further loss-of-function allele in DNAJC3 and no further associations in subjects with only a subset of the features of the main phenotype. Our findings demonstrate that loss-of-function DNAJC3 mutations lead to a monogenic, recessive form of diabetes mellitus in humans. Moreover, they present a common denominator for diabetes and widespread neurodegeneration. This complements findings from mice in which knockout of Dnajc3 leads to diabetes and modifies disease in a neurodegenerative model of Marinesco-Sjögren syndrome.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 1
542 _ _ |i 2014-12-01
|2 Crossref
|u https://www.elsevier.com/tdm/userlicense/1.0/
542 _ _ |i 2015-06-04
|2 Crossref
|u https://www.elsevier.com/open-access/userlicense/1.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a DNAJC3 protein, human
|2 NLM Chemicals
650 _ 7 |a HSP40 Heat-Shock Proteins
|2 NLM Chemicals
650 _ 7 |a Heat-Shock Proteins
|2 NLM Chemicals
650 _ 7 |a molecular chaperone GRP78
|0 YCYIS6GADR
|2 NLM Chemicals
650 _ 2 |a Endoplasmic Reticulum Chaperone BiP
|2 MeSH
650 _ 2 |a Adolescent
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Ataxia: genetics
|2 MeSH
650 _ 2 |a Diabetes Mellitus, Type 1: diagnostic imaging
|2 MeSH
650 _ 2 |a Diabetes Mellitus, Type 1: genetics
|2 MeSH
650 _ 2 |a Exome: genetics
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Fibroblasts
|2 MeSH
650 _ 2 |a Gene Expression Regulation
|2 MeSH
650 _ 2 |a HSP40 Heat-Shock Proteins: genetics
|2 MeSH
650 _ 2 |a HSP40 Heat-Shock Proteins: metabolism
|2 MeSH
650 _ 2 |a Heat-Shock Proteins: genetics
|2 MeSH
650 _ 2 |a Homozygote
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Models, Molecular
|2 MeSH
650 _ 2 |a Multiple System Atrophy: diagnostic imaging
|2 MeSH
650 _ 2 |a Multiple System Atrophy: genetics
|2 MeSH
650 _ 2 |a Mutation
|2 MeSH
650 _ 2 |a Pedigree
|2 MeSH
650 _ 2 |a Phenotype
|2 MeSH
650 _ 2 |a Radiography
|2 MeSH
650 _ 2 |a Sequence Analysis, DNA
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
700 1 _ |a Haack, Tobias B
|b 1
700 1 _ |a Kopajtich, Robert
|b 2
700 1 _ |a Gorza, Matteo
|b 3
700 1 _ |a Rapaport, Doron
|b 4
700 1 _ |a Greiner, Markus
|b 5
700 1 _ |a Schoenfeld, Caroline
|0 P:(DE-2719)9000290
|b 6
700 1 _ |a Freiberg, Clemens
|b 7
700 1 _ |a Schorr, Stefan
|b 8
700 1 _ |a Holl, Reinhard W
|b 9
700 1 _ |a Gonzalez, Michael A
|b 10
700 1 _ |a Fritsche, Andreas
|b 11
700 1 _ |a Fallier-Becker, Petra
|b 12
700 1 _ |a Zimmermann, Richard
|b 13
700 1 _ |a Strom, Tim M
|b 14
700 1 _ |a Meitinger, Thomas
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Züchner, Stephan
|b 16
700 1 _ |a Schüle, Rebecca
|0 P:(DE-2719)2812018
|b 17
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 18
700 1 _ |a Prokisch, Holger
|b 19
773 1 8 |a 10.1016/j.ajhg.2014.10.013
|b : Elsevier BV, 2014-12-01
|n 6
|p 689-697
|3 journal-article
|2 Crossref
|t The American Journal of Human Genetics
|v 95
|y 2014
|x 0002-9297
773 _ _ |a 10.1016/j.ajhg.2014.10.013
|g Vol. 95, no. 6, p. 689 - 697
|0 PERI:(DE-600)1473813-2
|n 6
|q 95:6<689 - 697
|p 689-697
|t The American journal of human genetics
|v 95
|y 2014
|x 0002-9297
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259973
856 4 _ |u https://pub.dzne.de/record/137691/files/DZNE-2020-04013_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/137691/files/DZNE-2020-04013_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:137691
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811275
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9000290
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)2812018
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)2810795
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Population Studies and Genetics
|x 1
914 1 _ |y 2014
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AM J HUM GENET : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b AM J HUM GENET : 2017
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
920 1 _ |0 I:(DE-2719)6000018
|k Tübingen common
|l Tübingen common
|x 1
920 1 _ |0 I:(DE-2719)5000024
|k AG Maetzler
|l Functional Neurogeriatrics
|x 2
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls
|l Clinical Neurogenetics
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)6000018
980 _ _ |a I:(DE-2719)5000024
980 _ _ |a I:(DE-2719)5000005
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21